Autoimmune Disease Diagnostics Market To Reach $8.20 Billion By 2030

Autoimmune Disease Diagnostics Market Growth & Trends

The global autoimmune disease diagnostics market size is estimated to reach USD 8.20 billion by 2030, expanding at a CAGR of 6.18% from 2025 to 2030, according to a new report by Grand View Research, Inc. Government organizations along with related associations strive to curb such high healthcare costs and simultaneously provide improved diagnostic and therapeutic solutions to the patients. This has resulted in increased funding by the NIH for R&D programs related to autoimmune diseases.

Moreover, the presence of favorable government initiatives aimed at curbing the incidence of these diseases and developing viable diagnostic & treatment options is expected to drive market growth over the forecast period.

Growing volume of autoimmune diagnostic procedures has heightened the need for instruments and facilities rendering faster and effective results. In an attempt to cater to ever-increasing procedure volumes, diagnostic laboratories are rapidly moving toward automation. Lab automation helps decrease workload via rapid turnaround times and helps generate standardized & reproducible results.

 Request a free sample copy or view report summary: Autoimmune Disease Diagnostics Market Report

Autoimmune Disease Diagnostics Market Report Highlights

• The localized autoimmune disease diagnostics segment dominated the market and accounted for a revenue share of 64.25% in 2024.

• The consumables & assays segment accounted for the largest revenue share of 70.43% in 2024. Every laboratory diagnostic test utilizes test kits, reagents, and antibodies.

• In terms of test type, the antinuclear antibody tests dominated the market with a revenue share of 42.62% in 2024. The growth of this segment is attributed to affordability, high sensitivity, and extensive availability.

• The hospital segment dominated the market in 2024 with a revenue share of 53.32%. The high share is attributed to the increased adoption of autoimmune disease diagnostic practices in hospitals for various diseases.

• The North America autoimmune disease diagnostics market dominated the global industry and accounted for a revenue share of 42.70% in 2024. The Asia Pacific autoimmune disease diagnostics market is anticipated to witness a fastest CAGR from 2024 to 2030.

Autoimmune Disease Diagnostics Market Segmentation

Grand View Research has segmented the global autoimmune disease diagnostics market based on type, product, test type, end use, and region:

Autoimmune Disease Diagnostics Type Outlook (Revenue, USD Million, 2018 - 2030)

• Systemic autoimmune disease diagnostics

  • Rheumatoid arthritis

  • Ankylosing spondylitis

  • Systemic lupus erythematosus (SLE)

  • Others

• Localized autoimmune disease diagnostics

  • Multiple sclerosis

  • Type 1 diabetes

  • Hashimoto's Thyroiditis

  • Idiopathic thrombocytopenic purpura

  • Others

Autoimmune Disease Diagnostics Product Outlook (Revenue, USD Million, 2018 - 2030)

• Instruments

• Consumables and Assays

Autoimmune Disease Diagnostics Test Type Outlook (Revenue, USD Million, 2018 - 2030)

• Antinuclear antibody tests

• Autoantibody tests

• C-reactive Protein (CRP)

• Complete blood count (CBC)

• Urinalysis

• Others

Autoimmune Disease Diagnostics End Use Outlook (Revenue, USD Million, 2018 - 2030)

• Hospitals

• Diagnostic centers

• Others

Autoimmune Disease Diagnostics Regional Outlook (Revenue, USD Million, 2018- 2030)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Sweden

  • Norway

  • Denmark

• Asia Pacific

  • Japan

  • China

  • India

  • Australia

  • Thailand

  • South Korea

• Latin America

  • Brazil

  • Argentina

• Middle East and Africa (MEA)

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players in Autoimmune Disease Diagnostics Market

• F. Hoffmann-La Roche Ltd

• Siemens Healthcare Private Limited

• Abbott

• Beckman Coulter, Inc.

• Danaher Corporation

• Quest Diagnostics

• EUROIMMUN Medizinische Labordiagnostika AG

• Nova Diagnostics Pte Ltd.

• BIOMÉRIEUX

• Hemagen Diagnostics, Inc.